VS
Veeravenkata Satyanarayana Murthy Talluri
About Veeravenkata Satyanarayana Murthy Talluri
Data last updated:
Veeravenkata Satyanarayana Murthy Talluri is a Managing Director at Haleos Labs Limited (since 2016) and Director at Mahi Drugs Private Limited (since 2018). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹385 Cr; the largest is Haleos Labs Limited at ₹350 Cr (FY 2025). Earlier, Veeravenkata Satyanarayana Murthy Talluri was a Director at Sms Pharmaceuticals Limited (2003–2021) and Director at Sreenivasa Pharma Private Limited (from 1999).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Haleos Labs Limited L74930TG2006PLC050223 | Managing Director | 01 Apr 2016 | 2006 | ₹350 Cr (FY 2025) | Active |
 Mahi Drugs Private Limited U24233AP2012PTC084875 | Director | 07 Apr 2018 | 2012 | ₹35.66 Cr (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sms Pharmaceuticals Limited L24239TG1987PLC008066 | Director | 11 Dec 2003 | 1987 | ₹789 Cr (FY 2025) | Active |
| Sreenivasa Pharma Private Limited U24230TG1995PTC020182 | Director | 25 Mar 1999 | 1995 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Veeravenkata Satyanarayana Murthy Talluri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mannam Malakondaiah | 01431923 | Haleos Labs Limited | Director |
| Nadella Rajendra Prasad | Haleos Labs Limited | Cfo | |
| Sarath Kumar Pakalapati | 01456746 | Haleos Labs Limited , Mahi Drugs Private Limited | Director |
| Srinivas Samavedam | 02488555 | Haleos Labs Limited | Director |
| Sudeepthi Gopineedi | 09102540 | Haleos Labs Limited | Whole-Time Director |
| Trupti Ranjan Mohanty | Haleos Labs Limited | Company Secretary | |
| Venkata Praveen Talluri | 08772030 | Haleos Labs Limited , Mahi Drugs Private Limited | Whole-Time Director |
| Madhu Rao Maganty | 08722559 | Mahi Drugs Private Limited | Nominee Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Veeravenkata Satyanarayana Murthy Talluri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veeravenkata Satyanarayana Murthy Talluri
Veeravenkata Satyanarayana Murthy Talluri currently holds 2 directorships: Haleos Labs Limited (Managing Director, since 01 Apr 2016, revenue ₹350 Cr (FY 2025)); Mahi Drugs Private Limited (Director, since 07 Apr 2018, revenue ₹35.66 Cr (FY 2023)).
Veeravenkata Satyanarayana Murthy Talluri was first appointed on 25 Mar 1999 as Director at Sreenivasa Pharma Private Limited. The most recent appointment on record is 07 Apr 2018 at Mahi Drugs Private Limited.
The 2 current companies of Veeravenkata Satyanarayana Murthy Talluri that report revenue have a combined latest revenue of ₹385 Cr: Haleos Labs Limited ₹350 Cr (FY 2025); Mahi Drugs Private Limited ₹35.66 Cr (FY 2023).
Veeravenkata Satyanarayana Murthy Talluri held 2 earlier board appointments: Sms Pharmaceuticals Limited (Director, 11 Dec 2003 to 28 May 2021); Sreenivasa Pharma Private Limited (Director, from 25 Mar 1999).
The current boards of Veeravenkata Satyanarayana Murthy Talluri's companies include Mannam Malakondaiah (Haleos Labs Limited), Nadella Rajendra Prasad (Haleos Labs Limited), Sarath Kumar Pakalapati (Haleos Labs Limited), Srinivas Samavedam (Haleos Labs Limited), Sudeepthi Gopineedi (Haleos Labs Limited), Trupti Ranjan Mohanty (Haleos Labs Limited), among others.